The efficacy of 4mg sumatriptan subcutaneous injection for the treatment of moderate to severe migraine attacks: A double-blind, placebo-controlled trial

被引：0

|

作者：

Wendt, J

Cady, R

Singer, R

Peters, K

Webster, CJ

Kori, S

Byrd, S

机构：

来源：

NEUROLOGY | 2006年 / 66卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：A255 / A255

页数：1

相关论文

共 50 条

[1] A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults
Wendt, Jeanette
Cady, Roger
Singer, Richard
Peters, Kenneth
Webster, Christopher
Kori, Shashidhar
Byrd, Susan
CLINICAL THERAPEUTICS, 2006, 28 (04) : 517 - 526
[2] Treatment with sumatriptan 50 mg in the mildphase of migraine attacks in patients withinfrequent attacks: A randomised, double-blind,placebo-controlled study
Tfelt-Hansen P.
Bach F.W.
Daugaard D.
Tsiropoulos I.
Riddersholm B.
The Journal of Headache and Pain, 2006, 7 (6) : 389 - 394
[3] A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine
Savani, N
Brautaset, NJ
Reunanen, M
Szirmai, I
Ashford, EA
Hassani, H
Saiers, J
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, : 7 - 15
[4] Relationships between productivity and clinical efficacy measures in a double-blind, placebo-controlled trial of sumatriptan in migraine
OQuinn, S
Jhingran, P
Pait, DG
Watson, C
Batenhorst, A
NEUROLOGY, 1997, 48 (03) : 4050 - 4050
[5] Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks. A randomized, double-blind, placebo-controlled study
Tfelt-Hansen, P
Bach, F
Daugaard, D
Tsiropoulos, I
Riddersholm, B
CEPHALALGIA, 2005, 25 (10) : 932 - 932
[6] Sumatriptan injection reduces productivity loss during a migraine attack - Results of a double-blind, placebo-controlled trial
Cady, RC
Ryan, R
Jhingran, P
O'Quinn, S
Pait, DG
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (09) : 1013 - 1018
[7] Efficacy of phenazone in the treatment of acute migraine attacks:: a double-blind, placebo-controlled, randomized study
Göbel, H
Heinze, A
Niederberger, U
Witt, T
Zumbroich, V
CEPHALALGIA, 2004, 24 (10) : 888 - 893
[8] Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan
Al-Shekhlee, A
Reed, R
NEUROLOGY, 2000, 55 (05) : 735 - 736
[9] Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan
Goadsby, PJ
Ferrari, MD
Olesen, J
Stovner, LJ
Senard, JM
Jackson, NC
Poole, PH
NEUROLOGY, 2000, 54 (01) : 156 - 163
[10] A double-blind, placebo-controlled, crossover, study to evaluate the efficacy of subcutaneous sumatriptan in the treatment of atypical facial pain
AlBalawi, S
Tariq, M
Feinmann, C
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1996, 86 (3-4) : 301 - 309

← 1 2 3 4 5 →